Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:07 PM
Ignite Modification Date:
2025-12-24 @ 9:07 PM
NCT ID:
NCT00615004
Eligibility Criteria:
Inclusion Criteria:
* Patients treated with first-line surgery via trans-sphenoidal route by microscopic and/or endoscopic approach or with first-line depot SSA treatment
* Achieving control of the disease; AND
* With available follow-up after 12 months of treatment
Exclusion Criteria:
* Patients receiving second surgery within 3 months from first surgery
* Requiring combined dopamine-agonists and SSA because of a mixed GH/PRL-secreting tumor
* Receiving the s.c. octreotide for longer than 15 days; OR
* Requiring surgery or SSA as second-line treatment before the completion of the 12 months or with a follow-up shorter than 6 months after surgery or pharmacotherapy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT00615004
Study Brief:
Protocol Section:
NCT00615004